Company Quick10K Filing
Cortexyme
10-Q 2021-03-31 Filed 2021-05-06
10-K 2020-12-31 Filed 2021-03-01
10-Q 2020-09-30 Filed 2020-11-12
10-Q 2020-06-30 Filed 2020-08-14
S-1 2020-04-07 Public Filing
10-Q 2020-03-31 Filed 2020-05-12
10-K 2019-12-31 Filed 2020-03-16
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-09
S-1 2019-04-12 Public Filing
10-Q 2019-03-31 Filed 2019-06-12
8-K 2021-02-12
8-K 2021-02-09
8-K 2021-01-26
8-K 2021-01-19
8-K 2020-12-04
8-K 2020-06-08
8-K 2020-05-18
8-K 2020-05-12
8-K 2020-04-27
8-K 2020-03-17
8-K 2020-02-05
8-K 2019-05-13

Cortexyme Financials

CRTX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2019-03-312019-06-302019-09-30
Cash59128120
Accounts Receivable
Inventory
PP&E000
Assets71143133
Accounts Payable252
Long-Term Debt
Liabilities476
Stockholders' Equity-38136127
Income Statement ($MM)2019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D578
SG&A122
Tax
Net Income-6-9-10
Cash Flow ($MM)2019-03-312019-06-302019-09-30
Cash Operating-7-6-9
Cash Investing3-489
Cash Financing0780